Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

led "The U.S. Is Secretly Helping The Taliban Fight ISIS In Afghanistan," writes that US Special Operations forces "intervene[d] in the fighting in Konar province in eastern Afghanistan...by using strikes from drones and other aircraft to help the Taliban." A member of the Joint Special Operations Command cou

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

led "The U.S. Is Secretly Helping The Taliban Fight ISIS In Afghanistan," writes that US Special Operations forces "intervene[d] in the fighting in Konar province in eastern Afghanistan...by using strikes from drones and other aircraft to help the Taliban." A member of the Joint Special Operations Command coun

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

led "The U.S. Is Secretly Helping The Taliban Fight ISIS In Afghanistan," writes that US Special Operations forces "intervene[d] in the fighting in Konar province in eastern Afghanistan...by using strikes from drones and other aircraft to help the Taliban." A member of the Joint Special Operations Command cou